Adiponectin promotes muscle regeneration through binding to T-cadherin.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
09 01 2019
Historique:
received: 17 07 2018
accepted: 29 11 2018
entrez: 11 1 2019
pubmed: 11 1 2019
medline: 31 12 2019
Statut: epublish

Résumé

Skeletal muscle has remarkable regenerative potential and its decline with aging is suggested to be one of the important causes of loss of muscle mass and quality of life in elderly adults. Metabolic abnormalities such as obesity were linked with decline of muscle regeneration. On the other hand, plasma levels of adiponectin are decreased in such metabolic conditions. However, plasma levels of adiponectin have been shown to inversely correlate with muscle mass and strength in elderly people especially with chronic heart failure (CHF). Here we have addressed whether adiponectin has some impact on muscle regeneration after cardiotoxin-induced muscle injury in mice. Muscle regeneration was delayed by angiotensin II infusion, mimicking aging and CHF as reported. Adiponectin overexpression in vivo decreased necrotic region and increased regenerating myofibers. Such enhanced regeneration by excess adiponectin was also observed in adiponectin null mice, but not in T-cadherin null mice. Mechanistically, adiponectin accumulated on plasma membrane of myofibers both in mice and human, and intracellularly colocalized with endosomes positive for a multivesicular bodies/exosomes marker CD63 in regenerating myofibers. Purified high-molecular multimeric adiponectin similarly accumulated intracellularly and colocalized with CD63-positive endosomes and enhanced exosome secretion in differentiating C2C12 myotubes but not in undifferentiated myoblasts. Knockdown of T-cadherin in differentiating C2C12 myotubes attenuated both adiponectin-accumulation and adiponectin-mediated exosome production. Collectively, our studies have firstly demonstrated that adiponectin stimulates muscle regeneration through T-cadherin, where intracellular accumulation and exosome-mediated process of adiponectin may have some roles.

Identifiants

pubmed: 30626897
doi: 10.1038/s41598-018-37115-3
pii: 10.1038/s41598-018-37115-3
pmc: PMC6327035
doi:

Substances chimiques

ADIPOQ protein, human 0
Adiponectin 0
Adipoq protein, mouse 0
Cadherins 0
H-cadherin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

16

Commentaires et corrections

Type : ErratumIn

Références

Nat Med. 2015 Jan;21(1):76-80
pubmed: 25501907
JCI Insight. 2018 Apr 19;3(8):
pubmed: 29669945
J Clin Invest. 2010 Dec;120(12):4342-52
pubmed: 21041950
Geriatr Gerontol Int. 2018 Jun;18(6):839-846
pubmed: 29392822
Eur J Intern Med. 2013 Dec;24(8):818-23
pubmed: 24095654
Am J Cardiol. 2007 Aug 15;100(4):569-74
pubmed: 17697807
PLoS One. 2013;8(2):e56250
pubmed: 23418545
ScientificWorldJournal. 2011 Jul 28;11:1525-35
pubmed: 21805021
Cold Spring Harb Symp Quant Biol. 2011;76:101-11
pubmed: 21960527
Clin Endocrinol (Oxf). 2005 Jan;62(1):114-8
pubmed: 15638879
Exp Cell Res. 2008 Oct 15;314(17):3232-44
pubmed: 18775697
Nat Commun. 2018 Feb 23;9(1):800
pubmed: 29476074
Am J Pathol. 2017 Jul;187(7):1577-1585
pubmed: 28463682
Diabetes. 2016 Jan;65(1):188-200
pubmed: 26384382
Biochem Biophys Res Commun. 2014 Feb 7;444(2):224-9
pubmed: 24462873
Muscle Nerve. 1991 Jun;14(6):515-20
pubmed: 1852158
PLoS One. 2017 Oct 23;12(10):e0186719
pubmed: 29059221
Physiol Rev. 2013 Jan;93(1):23-67
pubmed: 23303905
J Biol Chem. 2017 May 12;292(19):7840-7849
pubmed: 28325833
Nat Med. 2014 Oct;20(10):1174-81
pubmed: 25194569
Diabetes Care. 2006 Jun;29(6):1357-62
pubmed: 16732021
Hum Mutat. 2012 Feb;33(2):402-10
pubmed: 22065538
Diabetes. 2007 Aug;56(8):2174-7
pubmed: 17513700
Nat Commun. 2015 May 14;6:7087
pubmed: 25971691
Hum Mol Genet. 2010 Dec 15;19(24):4955-64
pubmed: 20876611
J Biol Chem. 2003 Mar 14;278(11):9073-85
pubmed: 12496257
Cell. 2005 Jul 15;122(1):133-43
pubmed: 16009139
Arterioscler Thromb Vasc Biol. 2008 May;28(5):863-70
pubmed: 18309113
J Biol Chem. 2013 Aug 16;288(33):23823-32
pubmed: 23831688
Am J Cardiol. 2011 Nov 15;108(10):1432-7
pubmed: 21872196
Am J Hum Genet. 2010 Oct 8;87(4):545-52
pubmed: 20887962
Diabetes. 2011 Sep;60(9):2417-23
pubmed: 21771975
Cell Metab. 2014 Aug 5;20(2):368-375
pubmed: 24998914
J Biol Chem. 2003 Oct 10;278(41):40352-63
pubmed: 12878598
Diabetes. 2013 Dec;62(12):4277-83
pubmed: 24009259
Endocrinology. 2015 Mar;156(3):934-46
pubmed: 25514086
Am J Pathol. 2010 May;176(5):2414-24
pubmed: 20304955
Sci Rep. 2015 Sep 25;5:14453
pubmed: 26571361
J Biol Chem. 2013 Aug 23;288(34):24886-97
pubmed: 23824191
Cytokine. 2007 Jan;37(1):1-5
pubmed: 17383891
Eur Heart J. 2006 Oct;27(19):2300-9
pubmed: 16864609
J Atheroscler Thromb. 2010 Dec 26;17(12):1201-11
pubmed: 20948162
Annu Rev Pathol. 2013 Jan 24;8:441-75
pubmed: 23121053
Clin Endocrinol (Oxf). 2013 Aug;79(2):204-10
pubmed: 22963459
Skelet Muscle. 2015 Aug 07;5:25
pubmed: 26257862
FASEB J. 2017 Apr;31(4):1571-1583
pubmed: 28062540
Eur J Endocrinol. 2005 Jul;153(1):91-8
pubmed: 15994750

Auteurs

Yoshimitsu Tanaka (Y)

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.

Shunbun Kita (S)

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan. shunkita@endmet.med.osaka-u.ac.jp.
Department of Adipose Management, Graduate School of Medicine, Osaka University, Osaka, Japan. shunkita@endmet.med.osaka-u.ac.jp.

Hitoshi Nishizawa (H)

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.

Shiro Fukuda (S)

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.

Yuya Fujishima (Y)

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.

Yoshinari Obata (Y)

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.

Hirofumi Nagao (H)

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.

Shigeki Masuda (S)

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.

Yuto Nakamura (Y)

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.

Yuri Shimizu (Y)

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.

Ryohei Mineo (R)

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.

Tomoaki Natsukawa (T)

Department of emergency & intensive care, Yodogawa Christian Hospital, Osaka, Japan.

Tohru Funahashi (T)

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.
Department of Metabolism and Atherosclerosis, Graduate School of Medicine, Osaka University, Osaka, Japan.

Barbara Ranscht (B)

Sanford Burnham Prebys Medical Discovery Institute, NIH-designated Cancer Center, Development, Aging and Regeneration Program, La Jolla, CA, USA.

So-Ichiro Fukada (SI)

Laboratory of Molecular and Cellular Physiology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.

Norikazu Maeda (N)

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.
Department of Metabolism and Atherosclerosis, Graduate School of Medicine, Osaka University, Osaka, Japan.

Iichiro Shimomura (I)

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH